Search Results 221-230 of 16567 for ������������KA���:ZA31���24������ ���������������������������������

  1. Joel Streed | Mayo Clinic News Network - Page 25 of 170

    They had three children already and thought this ultrasound would be as routine as the ones that had[...] By Joel Streed • April 24, 2022 ... 24 · 25 · 26 · 27 ...

  2. Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)

    Jacksonville, Florida: 24-011255; Scottsdale/Phoenix, Arizona: 24-011255. NCT ID: NCT06556654. Sponsor Protocol Number: TBR 22-07. About this study. This record ...

  3. Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer - Mayo Clinic

    ... 24 months prior to the most recent CIS diagnosis Cohort B: -Participants with persistent or recurrent CIS (± Ta/T1) who are BCG unresponsive within 12 ...

  4. Uterine fibroids - Doctors and departments - Mayo Clinic

    Learn about these common noncancerous growths and what to do if you have symptoms such as heavy menstrual bleeding.

  5. Publications - Leslie T. Cooper, Jr., M.D. - Mayo Clinic

    2025 Apr 24 [Epub ahead of print] View ... 2022 Nov; 24 (11):2000-2018 Epub 2022 Oct 06. View ... Matsumori A, Auda ME, Bruno KA, Shapiro KA, Kato ...

  6. Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease - Mayo Clinic

    Rochester, Minnesota: 24-012593. NCT ID: NCT06548542. Sponsor Protocol Number: AbbVie M24-885. About this study. Crohn's disease (CD) is a long-lasting disease ...

  7. Clinical Trials - CONVERGE Post-Approval Study (PAS)

    Rochester, Minnesota: 24-009046. NCT ID: NCT05393180. Sponsor Protocol Number: CP2021-1. About this study. The primary objective of CONVERGE PAS is to evaluate ...

  8. Laminar LAAX Pivotal IDE Study - Mayo Clinic

    Rochester, Minnesota: 24-011409. NCT ID: NCT06168942. Sponsor Protocol ... 24. Subject unable to undergo general anesthesia. 25. Subject with condition ...

  9. ... FX24,378 278000026,28399,CATHETER CV 45CMX28FR PLNDRM 2 LUM VENATRAC 16FRX28CM,498.12 278000026,28408,CATH QNT HD PERIT 57,125.86 278000026,4076,CATHETER ...

  10. Chemotherapy Combined With Immunotherapy vs Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial - Mayo Clinic

    Eau Claire, Wisconsin: 24-010192; Mankato, Minnesota: 24-010192. NCT ID: NCT06096844. Sponsor Protocol Number: EA5221. About this study. This phase III trial ...